Your browser doesn't support javascript.
loading
Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib.
Gángó, Ambrus; Alpár, Donát; Galik, Bence; Marosvári, Dóra; Kiss, Richárd; Fésüs, Viktória; Aczél, Dóra; Eyüpoglu, Ediz; Nagy, Noémi; Nagy, Ákos; Krizsán, Szilvia; Reiniger, Lilla; Farkas, Péter; Kozma, András; Ádám, Emma; Tasnády, Szabolcs; Réti, Marienn; Matolcsy, András; Gyenesei, Attila; Mátrai, Zoltán; Bödör, Csaba.
Afiliação
  • Gángó A; MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Alpár D; MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Galik B; Bioinformatics Research Group, Bioinformatics and Sequencing Core Facilities, Szentágothai Research Centre, University of Pécs, Pécs, Hungary.
  • Marosvári D; Department of Clinical Molecular Biology, Medical University of Bialystok, Bialystok, Poland.
  • Kiss R; MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Fésüs V; MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Aczél D; MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Eyüpoglu E; MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Nagy N; MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Nagy Á; MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Krizsán S; MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Reiniger L; MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Farkas P; MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Kozma A; 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Ádám E; Department of Haematology and Stem Cell Transplantation, St. István and St. László Hospital, Budapest, Hungary.
  • Tasnády S; Department of Haematology and Stem Cell Transplantation, St. István and St. László Hospital, Budapest, Hungary.
  • Réti M; Department of Haematology and Stem Cell Transplantation, St. István and St. László Hospital, Budapest, Hungary.
  • Matolcsy A; Department of Haematology and Stem Cell Transplantation, St. István and St. László Hospital, Budapest, Hungary.
  • Gyenesei A; MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Mátrai Z; Bioinformatics Research Group, Bioinformatics and Sequencing Core Facilities, Szentágothai Research Centre, University of Pécs, Pécs, Hungary.
  • Bödör C; Department of Clinical Molecular Biology, Medical University of Bialystok, Bialystok, Poland.
Int J Cancer ; 146(1): 85-93, 2020 01 01.
Article em En | MEDLINE | ID: mdl-31180577
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Leucemia Linfocítica Crônica de Células B / Inibidores de Proteínas Quinases / Mutação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Leucemia Linfocítica Crônica de Células B / Inibidores de Proteínas Quinases / Mutação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article